Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy
Nom du journal : J Clin Oncol
Année : 2007
Volume : 25
Page de départ : 3415
Page de fin : 3420